Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
J Drugs Dermatol ; 22(1): 29-34, 2023 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-36607760

RESUMO

The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following procedural treatments or interventions. Research and recommendations surrounding the risk for koebnerization within scarring alopecias is extremely limited. Using a comprehensive literature review, we summarized the risks of procedures in potentially koebnerizing alopecias. We evaluated the risk not only with procedural treatments, but also with common elective cosmetic procedures and potentially trauma-inducing hairstyling techniques. Although additional studies are needed to better elucidate the risks of procedural treatments within primary scarring alopecia, we believe this review of the current evidence and expert insight will benefit healthcare providers and patients alike to help guide treatments in this challenging patient population. J Drugs Dermatol. 2023;22(1):29-34. doi:10.36849/JDD.6849.


Assuntos
Alopecia , Cicatriz , Humanos , Cicatriz/diagnóstico , Cicatriz/etiologia , Cicatriz/terapia , Alopecia/diagnóstico , Alopecia/etiologia , Alopecia/tratamento farmacológico , Pessoal de Saúde
2.
J Drugs Dermatol ; 21(2): 206-208, 2022 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-35133119

RESUMO

Evidence-based literature regarding management of rare and severe dermatologic disease is limited. Canakinumab and anakinra, two therapeutics used for inhibiting IL-1 pathways, have seen increased utilization for treatment of refractory dermatoses. We sought to better characterize the breadth of dermatologic conditions for which these medications could be utilized.


Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1 , Dermatopatias/tratamento farmacológico , Humanos , Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico , Interleucina-1/antagonistas & inibidores , Resultado do Tratamento
3.
J Drugs Dermatol ; 21(12): 1316-1321, 2022 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-36468968

RESUMO

BACKGROUND: Social media platforms continue to grow in popularity and have become common sources of medical information and education for patients struggling with hair loss. OBJECTIVE: We sought to determine the characteristics of popular hair loss related content on Instagram and TikTok. METHODS: The top 9 most popular posts within 10 hair loss related hashtags on Instagram and TikTok were analyzed. Quantitative and qualitative analysis was used to evaluate posts from December 2020. The characteristic of the author, content category, and number of likes were analyzed for each post. RESULTS: Of 90 posts analyzed within Instagram, non-medical professional influencers created 66%, hair and wig companies created 29%, and medical professionals created 4%. Of 100 posts analyzed within TikTok, influencers created 38%, patients created 38%, hair and wig companies created 14%, and medical professionals created 10%. None of the top posts was created by board-certified dermatologists. LIMITATIONS: This study was limited by the extent of data that can be collected from Instagram and TikTok. CONCLUSIONS: A majority of the content promoted hair care products, services, or treatments not substantiated by evidence-based medicine. Instagram and TikTok provide new opportunities for dermatologists to educate the general population on alopecia while simultaneously correcting misinformation. J Drugs Dermatol. 2022;21(12):1316-1321. doi:10.36849/JDD.6707.


Assuntos
Mídias Sociais , Humanos , Emoções , Alopecia/diagnóstico , Alopecia/epidemiologia , Alopecia/etiologia
12.
Am J Clin Dermatol ; 22(5): 681-692, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34347282

RESUMO

Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent. The main goals of treatment are reducing symptoms and preventing disease progression and further hair loss. Currently, the literature has limited evidence on treatments for this difficult condition, and most available evidence is from case reports and case series. Furthermore, the evidence shows a varied response to therapy, with frequent reports of poor response. This article reviews the diagnosis of this rare disease, summarize the currently available treatments, and provide insights and practices from alopecia experts.


Assuntos
Líquen Plano/diagnóstico , Líquen Plano/terapia , Dermatoses do Couro Cabeludo/diagnóstico , Dermatoses do Couro Cabeludo/terapia , Humanos , Couro Cabeludo/patologia , Dermatoses do Couro Cabeludo/patologia
13.
Cutis ; 102(5): 335-338, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30566548

RESUMO

Frontal fibrosing alopecia (FFA) was first described as a progressive recession of the frontal hairline in postmenopausal women. Since its initial description, recognition and understanding of FFA has expanded. The condition is now defined as a patterned, symmetric, frontotemporal scarring alopecia that is considered to be histopathologically indistinguishable from lichen planopilaris. Numerous case reports and series have suggested clinical variants of and associations with FFA. In addition to reviewing the literature on FFA's associations, this article includes a case series of 5 women with skin of color (Hispanic and black) who presented with various cutaneous findings in association with FFA, including lichen planus pigmentosus (LPP), facial papules, and eyebrow loss. Recognition of the conditions that can occur in association with FFA in individuals with skin of color is important in further expanding our knowledge and understanding of FFA as a disease entity.


Assuntos
Alopecia/diagnóstico , Pigmentação da Pele , Adulto , Diagnóstico Diferencial , Sobrancelhas , Feminino , Testa , Humanos , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA